denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: educational grants from Incyte Corporation; Kadmon Corporation, LLC.; and Mallinckrodt Pharmaceuticals
Program: Satellite Symposia
Hematology Disease Topics & Pathways:
Biological, Diseases, Bone Marrow Failure, Therapies, checkpoint inhibitors, Clinically relevant, transplantation
Hematology Disease Topics & Pathways:
Biological, Diseases, Bone Marrow Failure, Therapies, checkpoint inhibitors, Clinically relevant, transplantation
Friday, December 4, 2020: 7:00 PM-10:00 PM
Chair:
James L. Ferrara, MD, Pediatrics, Medicine, Hematology and Medical Oncology and Oncological Sciences The Icahn School of Medicine at Mount Sinai
Disclosures:
No relevant conflicts of interest to declare.
Speakers:
Carrie Lynn Kitko, MD, Vanderbilt University Medical Center
,
Iskra Pusic, MD, Washington University School of Medicine in St. Louis
and
Robert Zeiser, MD, Medical Center - University of Freiburg
Disclosures:
Pusic: Incyte: Membership on an entity's Board of Directors or advisory committees; Kadmon: Membership on an entity's Board of Directors or advisory committees. Zeiser: Incyte: Honoraria; Malinckrodt: Honoraria; Novartis: Honoraria.
Leveraging Clinical Data and Trials to Inform Treatment for Patients With GvHD: An Expert Case Discussion will highlight recent advances in the treatment and prevention of acute and chronic graft-versus-host disease (GvHD). This program features expert faculty specializing in hematologic oncology and transplantation presenting the most recent clinical data of therapeutic agents in development, biomarkers for predicting risk, and the recognition and mitigation of treatment-related adverse events caused by GvHD treatments. This program is designed to be interactive through a combination of didactic presentations, challenging case studies, panel discussions, and a question-and-answer session to allow you the opportunity to hear from experts in the field regarding your most challenging clinical scenarios.
See more of: Satellite Symposia